What is SBIO's market cap?

$210M, based on the Sep 28 close of $57.93.

NYSE Arca · SBIO

ALPS Medical Breakthroughs ETF (SBIO)

$57.93+0.64%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$57.93▲ 51.66% in range

Sep 29, 2025Low $38.20 · High $70.79Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

ALPS Medical Breakthroughs ETF closed at $57.93 on Sep 28, up 0.64%, 18.2% below its 52-week closing high. Volume of 29.7K shares was 0.73× its 20-day average (below normal).

Split-adjusted performance: -16.7% over one month, +19.8% over six months, +57.2% over one year.

Short interest was 13.4K shares at the Sep 15 settlement, down 78.3% from the prior report (1.0 days to cover).

Market cap$210.0M3.6M shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yieldNone$1.1735 last paid

52-week range36.84 – 70.79−18.2% from high

Volume29.7K0.73× 20-day avg

Volatility · 60d30.4%Annualised

Short % of float—1.0 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W −7.1%1M −16.7%3M −10.3%6M +19.8%YTD +13.1%1Y +57.2%3Y +108.5%5Y +25.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short13.4K−78.3% vs prior

Days to cover1.0Settled Sep 15

% of float—

Short vol. 10d27.1%of daily volume

News about ALPS Medical Breakthroughs ETF

All news →

Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?Zacks Investment Research · Sep 8, 2026Neutral

Quick answers

What is SBIO's market cap?: $210M, based on the Sep 28 close of $57.93.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology